Podium Presentation Title: Tranexamic Acid has no Effect on Postoperative Hemarthrosis or Pain After Tibial Tubercle Osteotomy

Tranexamic acid (TXA) is an antifibrinolytic, commonly utilized in orthopedic procedures for the purpose of reducing perioperative bleeding and need transfusion. The this double-blinded randomized controlled trial was to evaluate use TXA patients undergoing TTO reduce post-operative intra-articular hemarthrosis. A double-blind conducted who underwent TTO. Fifty were equally control experimental groups. group received two 1-gram boluses IV TXA, one prior tourniquet inflation wound closure; did not receive TXA. following outcomes documented: blood loss (cc), postoperative hemarthrosis Visual Analog Scale (VAS) on days (POD) 1-7 visits (POV) 1-3, opioid consumption POD (morphine mg equivalents), range motion (ROM) ability straight leg raise (SLR) at POV pre- thigh circumference ratio (TCR). There no significant difference found between groups (64.25cc v. 60cc, p=0.38). No statistical significance observed patient demographic characteristics. All available first evaluation. 3 knees aspirated each groups; with (3.3cc 14cc, p=0.09). Significantly reduced levels pain seen throughout week both (p=0.022, p<0.0001), but reduction VAS score (p=0.15). noted by end (120.21mg 120.58mg, p=0.5). ROM or SLR all three visits. nor TCR (p=0.15, p=0.70). Intravenous undergo does significantly impact loss, hemarthrosis, levels. Additionally, ROM, SLR, TCR.